SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001546927-16-000410
Filing Date
2016-02-12
Accepted
2016-02-12 13:00:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 opaleye13gtrillum13g2015.txt SC 13G/A 14439
  Complete submission text file 0001546927-16-000410.txt   15883
Mailing Address 175 FEDERAL STREET, 6TH FLOOR BOSTON MA 02110
Business Address 175 FEDERAL STREET, 6TH FLOOR BOSTON MA 02110 617-904-9195
Opaleye Management Inc. (Filed by) CIK: 0001595855 (see all company filings)

IRS No.: 205648796 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9
Business Address 96 SKYWAY AVENUE TORONTO A6 M9W 4Y9 (416) 595-0627
Trillium Therapeutics Inc. (Subject) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: SC 13G/A | Act: 34 | File No.: 005-88719 | Film No.: 161417145
SIC: 2834 Pharmaceutical Preparations